Regulatory Affairs

 

Seven of FDASmart ’s Training Classes

 

Class Title

Description

1

What Needs To Be In A Product Submission: An FDA Reviewer’s Perspective

A discussion of how FDA reviewers think and work and how to use that information to improve the structure and content to a submission.

2

FDA’s New Guidance and Enforcement: Company Web Sites, Email & Online Advertising

An overview of recent FDA actions affecting Internet communication about products and product risk.

3

Foreign Clinical Studies: New FDA Regulations

A review of the new 21 CFR 312.120 regulations, published in the Federal Register on April 28, 2008, about good clinical practice requirements for non-IND foreign clinical trials.

4

Implementing FDA’s 2008 Guidance on the Integrated Summary of Effectiveness (ISE)

A discussion of FDA’s new recommendations on the ISE section of an NDA or BLA submission.

5

Annual Reports: SOPs for Developing Content That Meets FDA Requirements

A discussion about annual report SOPs for drugs, biologics and devices that will produce content that meets FDA regulatory requirements. INCLUDES FIVE MODEL SOPs

6

Survey of FDA Reviewer Training:
Understanding Reviewer Strategies, Tools, & Techniques

A discussion about how FDA reviewers are trained and how to use that information to build better submissions.

7

Good Review Management: FDA’s Internal Standards and Expectations of Industry

A discussion standards and processes meant to improve FDA performance and the quality of submissions produced by regulated industry.